(Q33347665)

26 July 2017

title

Phase II study of MGI-114 administered intravenously for 5 days every 28 days to patients with metastatic colorectal cancer (English)

1 reference

26 July 2017

Phase II Study of MGI-114 Administered Intravenously for 5 Days Every 28 Days to Patients With Metastatic Colorectal Cancer (English)

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00006

27 December 2023

1 reference

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00006

27 December 2023

author

James Lewis Abbruzzese

6

object named as

James Abbruzzese

1 reference

26 July 2017

Sunita Dwivedy Nasta

1

1 reference

26 July 2017

Marcus Neubauer

4

1 reference

26 July 2017

Rodger Winn

7

1 reference

26 July 2017

Paulo M. Hoff

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714882

27 December 2023

Christopher S. George

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714882

27 December 2023

Steven C. Cohen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714882

27 December 2023

James Abbruzzese

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714882

27 December 2023

Richard M. Pazdur

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12714882

27 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12714882

27 December 2023

publication date

1 April 2003

1 reference

full work available at URL

26 July 2017

https://journals.lww.com/00000421-200304000-00006

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00006

American Journal of Clinical Oncology

27 December 2023

published in

1 reference

26 July 2017

volume

26

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

132-134

1 reference

Cancer incidence and mortality: the priority of screening frequency and population coverage

26 July 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00006

Colorectal cancer follow-up: perspectives for future studies

27 December 2023

2

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00006

Acylfulvenes, a new class of potent antitumor agents

27 December 2023

3

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00006

(Hydroxymethyl)acylfulvene: an illudin derivative with superior antitumor properties

27 December 2023

4

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00006

Characterization of cellular accumulation and toxicity of illudin S in sensitive and nonsensitive tumor cells

27 December 2023

5

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00006

Antitumor activity of MGI 114 (6-hydroxymethylacylfulvene, HMAF), a semisynthetic derivative of illudin S, against adult and pediatric human tumor colony-forming units

27 December 2023

6

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00006

Efficacy of HMAF (MGI-114) in the MV522 metastatic lung carcinoma xenograft model nonresponsive to traditional anticancer agents

27 December 2023

8

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00006

Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignancies.

27 December 2023

9

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00006

Optimal two-stage designs for phase II clinical trials

27 December 2023

10

1 reference

https://api.crossref.org/works/10.1097/00000421-200304000-00006

27 December 2023

Identifiers

1 reference

26 July 2017

1 reference